Patents by Inventor Kenneth Martin Curry

Kenneth Martin Curry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230293344
    Abstract: Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled delivery of one or more drugs to the eye of a patient.
    Type: Application
    Filed: January 24, 2023
    Publication date: September 21, 2023
    Inventors: Thomas W. Burns, Douglas Daniel Crimaldi, David Applegate, Kenneth Martin Curry
  • Patent number: 11564833
    Abstract: Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled delivery of one or more drugs to the eye of a patient.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: January 31, 2023
    Assignee: GLAUKOS CORPORATION
    Inventors: Thomas W. Burns, Douglas Daniel Crimaldi, David Applegate, Kenneth Martin Curry
  • Patent number: 11564569
    Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: January 31, 2023
    Assignee: GLAUKOS CORPORATION
    Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
  • Publication number: 20220330819
    Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.
    Type: Application
    Filed: June 20, 2022
    Publication date: October 20, 2022
    Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
  • Publication number: 20220313486
    Abstract: Disclosed herein are implantable intraocular drug delivery devices structured to provide targeted and/or controlled release of a drug to a desired intraocular target tissue, and methods of implanting and methods of using such devices for the treatment of ocular diseases and disorders. In certain embodiments, some, most, or essentially all of the device is made of biodegradable materials.
    Type: Application
    Filed: April 22, 2022
    Publication date: October 6, 2022
    Inventors: Harold Alexander Heitzmann, David Steven Haffner, Kenneth Martin Curry, Thomas W. Burns
  • Patent number: 11363951
    Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: June 21, 2022
    Assignee: GLAUKOS CORPORATION
    Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
  • Patent number: 11318043
    Abstract: An ocular implant configured for implantation into the eye of a subject comprising an elongate outer shell (54), an internal plug (210) including a hydrogel and a drug reservoir including a drug (62) wherein the drug is configured to pass through at least a portion of the internal plug to control elution of the drug through the outer shell. The implant is made of biodegradable materials.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: May 3, 2022
    Assignee: DOSE MEDICAL CORPORATION
    Inventors: Harold Alexander Heitzmann, David Steven Haffner, Kenneth Martin Curry, Thomas W. Burns
  • Publication number: 20190125581
    Abstract: An ocular implant configured for implantation into the eye of a subject comprising an elongate outer shell (54), an internal plug (210) including a hydrogel and a drug reservoir including a drug (62) wherein the drug is configured to pass through at least a portion of the internal plug to control elution of the drug through the outer shell. The implant is made of biodegradable materials.
    Type: Application
    Filed: April 20, 2017
    Publication date: May 2, 2019
    Inventors: Harold Alexander Heitzmann, David Steven Haffner, Kenneth Martin Curry, Thomas W. Burns
  • Publication number: 20190053704
    Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.
    Type: Application
    Filed: July 11, 2018
    Publication date: February 21, 2019
    Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
  • Publication number: 20130090534
    Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.
    Type: Application
    Filed: September 12, 2012
    Publication date: April 11, 2013
    Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales